Tag: GLP-1

Eli Lilly and Company
Valuation Analysis
USA

Valuation Analysis: Eli Lilly and Company

Eli Lilly remains one of the biggest beneficiaries of the GLP-1 boom. Strong fundamentals, growth in Mounjaro and Zepbound, and
Active icon
Continue Umbrella
Eli Lilly
Pharmaceuticals
USA

Stock: Eli Lilly and Company

Eli Lilly is one of the leading pharmaceutical companies and benefits significantly from the growth in GLP-1 drugs for diabetes
Active icon
Continue Umbrella